Skip to main content
. 2026 Jul 3;17:1826684. doi: 10.3389/fneur.2026.1826684

Table 2.

Favorable and unfavorable outcome at Follow Up; (A) GOSE; (B) BI.

(A) Favorable and unfavorable outcome (GOSE) at Follow Up
GOSE UDC BDC
Favorable outcome (GOSE 5–8) 10 (40.0%) 5 (20.0%)
Unfavorable outcome (GOSE 1–4) 6 (24.0%) 12 (48.0%)
Total of patients reached at Follow Up 16 (64.0%) 17 (68.0%)
(B) Favorable and unfavorable Outcome (BI) at Follow Up
Barthel Index UDC BDC
Favorable outcome (BI >85) 10 (40.0%) 6 (24.0%)
Unfavorable outcome (BI <85) 3 (12.0%) 6 (24.0%)
Total of patients reached at Follow Up 13 (52.0%) 12 (48.0%)